IP Library Granted Patent US 8,383,399
Granted Patent B2
US 8,383,399 · App. 13/179,281 · Granted Feb 26, 2013

Nucleic acid construct having an ovalbumin promotor

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,383,399
App. No.
13/179,281
Granted
Feb 26, 2013
Kind
B2
Abstract

A transgenic avian containing in its genome an exogenous nucleotide sequence which includes a promoter component and a vector with reduced promoter interference wherein the exogenous nucleotide sequence is integrated into the genome and the avian.

Claims (12)

1. An isolated nucleic acid molecule at least 95% identical to a nucleic acid molecule comprising:

a 5′ LTR as set forth in SEQ ID NO:29;

an ovalbumin promoter fragment comprising DHS I & II as set forth in the nucleotide sequence 5209 through 8311 of SEQ ID NO:22;

reverse responsive element as set forth in SEQ ID NO:25;

constitutive transport element as set forth in SEQ ID NO:26

a 3′ UTR as set forth in the nucleotide sequence 13576 through 15163 of SEQ ID NO:22.

2. An isolated vector comprising the nucleic acid molecule of claim 1 .

3. The vector of claim 2 , wherein the vector is a self-inactivating vector derived from a retrovirus.

4. The vector of claim 3 , wherein the retrovirus is selected from the group consisting of an avian leukosis virus (ALV), a murine leukemia virus (MLV), a moloney murine leukemia virus (MMLV) and a lentivirus.

5. The vector of claim 4 , wherein the retrovirus is an avian leukosis virus.

6. The vector of claim 5 , wherein the self-inactivation vector has no selectable marker.

7. An isolated host cell containing the vector of claim 2 .

Assignments (2)
MERGER AND CHANGE OF NAME Recorded Jun 10, 2016
From: SYNAGEVA BIOPHARMA CORP.; GALAXY MERGER SUB LLC
To: ALEXION PHARMA LLC
Reel/Frame 038877/0978 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 10, 2016
From: ALEXION PHARMA LLC.
To: ALEXION PHARMACEUTICALS, INC.
Reel/Frame 038880/0563 →